Close

Penumbra, Inc. (PEN) Announces Penumbra 3D Trial Met Primary Endpoints

July 27, 2016 12:30 PM EDT Send to a Friend
Penumbra, Inc. (NYSE: PEN) announced that the Penumbra 3D Trial successfully met the primary trial endpoints, demonstrating non-inferiority in both ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login